Back to Rheumatology
Rheumatologyvvan_der_helm_2007Evidence-Based

Leiden Clinical Prediction Rule for Undifferentiated Arthritis

Diagnoses rheumatoid arthritis in patients with recent-onset undifferentiated arthritis by predicting the likelihood of progression from undifferentiated arthritis to rheumatoid arthritis within one year

Clinical Input Parameters

years
Range: 18 — 120 years
joints
Range: 0 — 68 joints
joints
Range: 0 — 66 joints
mg/L
Range: 0 — 500 mg/L
Clinical Assessment
Awaiting Parameters
leiden prediction score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Leiden Clinical Prediction Rule for Undifferentiated Arthritis is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within rheumatology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Score = (Age × 0.02) + Sex points + Joint distribution points + Symmetric distribution points + Morning stiffness points + Tender joints points + Swollen joints points + CRP points + RF points + Anti-CCP points

Clinical Pearls & Practice Notes

  • Developed from the Leiden Early Arthritis Clinic cohort study
  • Applies to adults with recent-onset undifferentiated arthritis (symptom duration <2 years)
  • Designed to predict progression to rheumatoid arthritis within 1 year
  • Score ranges from approximately 0 to 13 points
  • High specificity for identifying patients who will progress to RA
  • Should be used in conjunction with clinical judgment and other diagnostic criteria
  • Age component calculated as: age in years × 0.02
  • Validated across multiple populations and clinical settings
  • Helps guide early treatment decisions with DMARDs
  • Not intended to replace comprehensive rheumatological evaluation
  • Most accurate when applied to patients with symptom duration <6 months
  • Consider serial assessments for patients in indeterminate risk category

Evidence & Literature Citations

  1. van der Helm-van Mil AHM, le Cessie S, van Dongen H, Breedveld FC, Toes REM, Huizinga TWJ. A prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: how to guide individual treatment decisions. Arthritis Rheum. 2007 Feb;56(2):433-40.
  2. Kuriya B, Cheng CK, Chen HM, Bykerk VP. Validation of a prediction rule for development of rheumatoid arthritis in patients with early undifferentiated arthritis. Ann Rheum Dis. 2009 Sep;68(9):1482-5.
  3. Tamai M, Kawakami A, Uetani M, Fukushima A, Arima K, Iwanaga N, et al. A prediction rule for disease outcome in patients with undifferentiated arthritis using magnetic resonance imaging of the wrists and finger joints and serologic autoantibodies. Arthritis Rheum. 2009 Oct 15;61(10):1324-31.

Score Interpretation Ranges

Low Risk0 – 6 pts

Low risk of progression to rheumatoid arthritis

Indeterminate Risk6.01 – 7.99 pts

Indeterminate risk of progression to rheumatoid arthritis

High Risk8 – 20 pts

High risk of progression to rheumatoid arthritis

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.